Dexatrim Natural Fattens Chattem's First Quarter; Extensions Planned
This article was originally published in The Tan Sheet
Executive Summary
Sales of Chattem's Dexatrim line increased nearly 5% in the fiscal first quarter ended Feb. 28 compared to the year-ago period, despite the loss of the flagship phenylpropanolamine-containing products.